Risk factors and the impact of comorbidities in patients developing urethral stricture after transurethral resection of the prostate
- 18 May 2026
- journal article
- letter
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1)
Abstract
Urethral stricture remains a clinically relevant complication after transurethral resection of the prostate (TURP). While procedural factors have been extensively studied, the contribution of systemic comorbidities to stricture development is less well defined. This study aimed to evaluate the association between common cardiovascular and metabolic comorbidities and urethral stricture formation following TURP. A retrospective cohort of 713 patients who underwent bipolar TURP for benign prostatic hyperplasia between January 2021 and January 2024 was analyzed. Urethral stricture was identified in 47 patients (6.6%). Propensity score matching (1:4) was performed based on age, prostate volume, operative time, and PSA levels, yielding a matched cohort of 235 patients. Comorbidities including smoking, hypertension, diabetes mellitus, dyslipidemia, and coronary artery disease (CAD) were assessed using clinical records and prescription data. Univariable and multivariable Cox proportional hazards regression analyses were performed to identify factors associated with time to urethral stricture development. In the matched cohort, smoking, hypertension, CAD, and dyslipidemia were significantly more prevalent in patients who developed urethral stricture (all p < 0.05), whereas diabetes mellitus was not. In univariable Cox analysis, smoking (HR 2.13), hypertension (HR 2.76), CAD (HR 3.15), and dyslipidemia (HR 2.46) were significantly associated with an increased hazard of urethral stricture development. In multivariable Cox analysis, only CAD remained independently associated with the outcome (HR 2.06, 95% CI 1.02-4.16, p = 0.04). The most common stricture location was the bulbar urethra. Coronary artery disease was independently associated with urethral stricture development following TURP. Other comorbidities may contribute through overlapping vascular and metabolic pathways. These findings highlight the importance of systemic disease burden when assessing postoperative stricture risk and planning perioperative management.Keywords
This publication has 15 references indexed in Scilit:
- Construction of a nomogram to predict urethral stricture after transurethral resection of the prostate: A retrospective cohort studyPLOS ONE, 2025
- Incidence and management of BPH surgery-related urethral stricture: results from a large U.S. databaseProstate Cancer and Prostatic Diseases, 2024
- Incidence of urethral stricture following bipolar transurethral resection of prostateIndian Journal of Urology, 2022
- The rising worldwide impact of benign prostatic hyperplasiaBJU International, 2020
- Transurethral resection of the prostate stricture managementAsian Journal of Andrology, 2020
- Transurethral procedures in the treatment of benign prostatic hyperplasiaMedicine, 2018
- Incidence of urethral stricture after bipolar transurethral resection of the prostate using TUR is: results from a randomised trialBJU International, 2014
- Comparison of plasmakinetic transurethral resection of the prostate with monopolar transurethral resection of the prostate in terms of urethral stricture rates in patients with comorbiditiesProstate International, 2014
- Bipolar Transurethral Resection Versus Monopolar Transurethral Resection for Benign Prostatic Hypertrophy: A Systematic Review and Meta-AnalysisJournal of Endourology, 2014
- Oxygen in Wound Healing—More than a NutrientWorld Journal of Surgery, 2004